Related Experiment Videos
Activation of the factor VII-tissue factor pathway
1Department of Medicine, Brockton-West Roxbury Department of Veterane Affairs Medical Center, MA 02132, USA. bauer_md.kenneth_a.@brockton.va.gov
Thrombosis and Haemostasis
|July 1, 1997
Summary
New assays detect coagulation enzymes in vivo. Elevated levels of certain coagulation factors may increase the risk of arterial or venous thrombosis, requiring further study.
Area of Science:
- Biochemistry
- Hemostasis
- Thrombosis
Background:
- Advances in coagulation biochemistry enable sensitive in vivo detection of coagulation enzymes.
- The factor VII-tissue factor pathway is crucial for generating factor Xa and thrombin under normal conditions.
- This pathway also primarily activates factor IX, with minor input from the contact phase.
Purpose of the Study:
- To investigate the role of the factor VII-tissue factor pathway in coagulation.
- To explore the clinical significance of biochemically identified hypercoagulable states.
Main Methods:
- Development of sensitive and specific assays for detecting coagulation enzyme generation in vivo.
- Analysis of factor VII-tissue factor pathway activity and factor IX activation.
- Identification of individuals with elevated coagulation factor levels.
Main Results:
- The factor VII-tissue factor pathway generates factor Xa and thrombin in vivo.
- This pathway is the primary driver of factor IX activation, surpassing the contact phase.
- Elevated factor IXa levels do not appear to convert factor X to factor Xa under basal conditions.
Conclusions:
- The factor VII-tissue factor pathway plays a central role in initiating coagulation.
- Prospective studies are needed to determine if biochemical hypercoagulability predicts thrombosis risk.
- Identifying individuals with elevated coagulation factors may aid in predicting arterial and venous thrombosis.